|Application deadline:||Start in 1 February: September (non-EEA: September). Start in 1 September: April (non-EEA: April).|
|Tuition fee:|| |
|Start date:||September 2014, February 2015, September 2015|
|Credits (ECTS):||120 ECTS|
|Duration full-time:||24 months|
|Delivery mode:||On Campus|
|Educational variant:||Part-time, Full-time|
Become a StudyPortals member and get access to exclusive information, like scholarships and student reviews, related to your favourite programme!
Are you already a StudyPortals Member?
Find all members only information here
The Master's in Drug Innovation focuses on interdisciplinary research in the field of innovation and usage of drugs, biologicals (such as vaccines and gene therapeutics)and diagnostics.
Despite a better understanding of the underlying mechanisms of disease, the number of newly introduced innovative drugs is steadily decreasing. As drugs have proven to be effective and inexpensive weapons against disease in the 20th century (e.g. antibiotics and psychopharmaceuticals), it is important to reverse this worrying trend using innovative techniques. In this programme you will start with the 'Introduction to Drug Innovation', after which you select at least three courses from the introductory theoretical courses. Upon that you will choose elective courses, attend seminars and do a major and minor research project. The major project is carried out within Utrecht University. The minor project may be carried out in another organisation in the Netherlands or abroad. Your final thesis is based on a literature review of a relevant subject. As a graduate you will be eligible for many PhD programmes and be able to contribute to drug innovation within research institutes, any of the growing number of pharmaceutical and biotechnology companies or health care organisations. The programme is also offered as a part-time course.
Types of teaching (in year 1): * theory: 30%
* practice: 40%
* self study: 30%
Programme internationalization: * Studying abroad is optional.
* The percentage of foreign students: 50%
* The percentage of students abroad: 20%
This programme has a workload of 120 ECTS.
Drug Regulatory Sciences:
This profile aims to provide basic knowledge in the important new field of regulatory affairs. The six-month research project is replaced by courses and a traineeship.
This is a coherent track of courses and research projects to train students in Experimental Pharmacology.
Additional language requirements: * Cambridge Certificate in Advanced English: B1
* Cambridge Certificate of Proficiency in English: C1
* IELTS overall band: 6.5
* IELTS writing: 6
* TOEFL paper based: 580
* TOEFL computer based: 237
* TOEFL internet based: 93
| CAE score: (read more) |
Cambridge English: Advanced (CAE) is part of the Cambridge English suite and is targeted at a high level (IETLS 6.5-8.0). It is an international English language exam set at the right level for academic and professional success. Developed by Cambridge English Language Assessment - part of the University of Cambridge - it helps you stand out from the crowd as a high achiever.
|75 (Grade B)|
|TOEFL paper-based test score :||580|
|TOEFL iBT® test:||93|
Scholarships / Grants:
Utrecht University:The Utrecht Excellence Scholarship offers a number of highly talented prospective, non-Dutch students the opportunity to pursue a degree in a selected number of fields at Utrecht University.For additional information: Website
Utrecht University:This scholarship offers outstanding prospective non-Dutch students the opportunity to follow the Master's Programme in Legal Research at Utrecht University. Selected students are awarded a scholarship of up to a max. of â`¬5,000/year, for the duration of two years.For additional information: Website
Accredited by: NVAO in: Netherlands
Accredited by: NVAO in: Netherlands